Sickle Cell Disease in Social Security Disability Evaluations (2025)

Chapter: Appendix A: Public Meeting Agendas

Previous Chapter: 9 Overarching Conclusions
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 235
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 236
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 237
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 238
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 239
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 240
Next Chapter: Appendix B: Draft Medical Report Forms for Children and Adults with Sickle Cell Disease
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.